Arcturus Therapeutics Holdings Inc. (ARCT): Price and Financial Metrics
Arcturus Therapeutics Holdings Inc. (ARCT)
Today's Latest Price: $67.30 USD
Updated Jan 20 6:55pm
Add ARCT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ARCT Stock Summary
- With a one year PEG ratio of 0.64, Arcturus Therapeutics Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 6.04% of US stocks.
- ARCT's price/sales ratio is 160.52; that's higher than the P/S ratio of 97.24% of US stocks.
- Revenue growth over the past 12 months for Arcturus Therapeutics Holdings Inc comes in at -46.19%, a number that bests merely 6.23% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Arcturus Therapeutics Holdings Inc are EVGN, CLDX, KALV, SYBX, and FULC.
- ARCT's SEC filings can be seen here. And to visit Arcturus Therapeutics Holdings Inc's official web site, go to www.arcturusrx.com.
ARCT Stock Price Chart Interactive Chart >
ARCT Price/Volume Stats
| Current price | $67.30 | 52-week high | $129.71 |
| Prev. close | $68.45 | 52-week low | $8.51 |
| Day low | $66.41 | Volume | 1,873,300 |
| Day high | $72.48 | Avg. volume | 2,859,467 |
| 50-day MA | $74.57 | Dividend yield | N/A |
| 200-day MA | $51.92 | Market Cap | 1.65B |
Arcturus Therapeutics Holdings Inc. (ARCT) Company Bio
Arcturus Therapeutics Ltd a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company was founded in 2008 and is based in Tel Aviv, Israel.
Loading social stream, please wait...